In hematologic malignancies, DDX43 is overexpressed in acute myeloid leukemia (AML), CML, multiple myeloma and a variety of malignant cell lines derived from B or T lymphocytic cells [8, 10–13]. This evidence concerns the gene DDX43 and acute myeloid leukemia.